Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Emma McCabe & Margarete Parrish. (2018) A review of the complexities of working effectively with people being prescribed both antipsychotic medications and opioid substitution therapy. Drugs: Education, Prevention and Policy 25:1, pages 1-12.
Read now
Read now
Michael Soyka. (2017) Treatment of opioid dependence with buprenorphine: current update. Dialogues in Clinical Neuroscience 19:3, pages 299-308.
Read now
Read now
Philippe Binder, Nassir Messaadi, Marie-Christine Perault-Pochat, Stéphanie Gagey, Yann Brabant & Pierre Ingrand. (2016) Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment. Journal of Addictive Diseases 35:2, pages 101-108.
Read now
Read now
Michael Soyka. (2015) New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance Abuse and Rehabilitation 6, pages 1-14.
Read now
Read now
Michael Soyka. (2015) Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update. Expert Opinion on Drug Delivery 12:2, pages 339-347.
Read now
Read now
R Douglas Bruce, David E Moody, Frederick L Altice, Marc N Gourevitch & Gerald H Friedland. (2013) A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Review of Clinical Pharmacology 6:3, pages 249-269.
Read now
Read now
Paolo Mannelli, Kathleen S Peindl & Li-Tzy Wu. (2011) Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Substance Abuse and Rehabilitation 2, pages 113-123.
Read now
Read now
Articles from other publishers (22)
Christine Lee, Annabelle Wanson, Sarah Frangou, David Chong & Katelyn Halpape. (2021) Opioid toxicity due to CNS depressant polypharmacy: A case report. Mental Health Clinician 11:2, pages 70-74.
Crossref
Crossref
Marina Tsoy-Podosenin & Anil Thomas. 2020. Absolute Addiction Psychiatry Review. Absolute Addiction Psychiatry Review
169
184
.
Laura Fanucchi, Sandra A. Springer & P. Todd Korthuis. (2019) Medications for Treatment of Opioid Use Disorder among Persons Living with HIV. Current HIV/AIDS Reports 16:1, pages 1-6.
Crossref
Crossref
Maryam Khazaee-Pool, Maryam Moeeni, Koen Ponnet, Arezoo Fallahi, Leila Jahangiri & Tahereh Pashaei. (2018) Perceived barriers to methadone maintenance treatment among Iranian opioid users. International Journal for Equity in Health 17:1.
Crossref
Crossref
Jason Baker Fields, William F. Haning & Yngvild Olsen. 2018. The American Society of Addiction Medicine Handbook on Pain and Addiction. The American Society of Addiction Medicine Handbook on Pain and Addiction
221
242
.
R Douglas Bruce, Jessica Merlin, Paula J Lum, Ebtesam Ahmed, Carla Alexander, Amanda H Corbett, Kathleen Foley, Kate Leonard, Glenn Jordan Treisman & Peter Selwyn. (2017) 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clinical Infectious Diseases 65:10, pages e1-e37.
Crossref
Crossref
Martyna Sawicka & Derek K Tracy. (2017) Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review. Therapeutic Advances in Psychopharmacology 7:8-9, pages 211-224.
Crossref
Crossref
Stephen A. Bai, Qinfang Xiang & Andrew Finn. (2016) Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. Clinical Therapeutics 38:2, pages 358-369.
Crossref
Crossref
Janet K. Coller, Daniel T. Barratt & Andrew A. Somogyi. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
565
577
.
Aishwarya Vijay, Alexander R. Bazazi, Ilias Yee, Adeeba Kamarulzaman & Frederick L. Altice. (2015) Treatment Readiness, Attitudes Toward, and Experiences with Methadone and Buprenorphine Maintenance Therapy Among People Who Inject Drugs in Malaysia. Journal of Substance Abuse Treatment 54, pages 29-36.
Crossref
Crossref
K. O'Sullivan, U. Reulbach, F. Boland, N. Motterlini, D. Kelly, K. Bennett & T. Fahey. (2015) Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland. BMJ Open 5:6, pages e007070-e007070.
Crossref
Crossref
Hilary Smith Connery. (2015) Medication-Assisted Treatment of Opioid Use Disorder. Harvard Review of Psychiatry 23:2, pages 63-75.
Crossref
Crossref
Adeeba Kamarulzaman & Frederick L. Altice. (2015) Challenges in managing HIV in people who use drugs. Current Opinion in Infectious Diseases 28:1, pages 10-16.
Crossref
Crossref
Evan D. Kharasch & Kristi Stubbert. (2013) Cytochrome P4503A Does Not Mediate the Interaction between Methadone and Ritonavir-Lopinavir. Drug Metabolism and Disposition 41:12, pages 2166-2174.
Crossref
Crossref
Karen J. Regina & Evan D. Kharasch. (2013) High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography–mass spectrometry. Journal of Chromatography B 939, pages 23-31.
Crossref
Crossref
R. Douglas Bruce, Leo Beletsky, Sharon Stancliff & Sarah Bowman. (2013) The Reply. The American Journal of Medicine 126:11, pages e21-e22.
Crossref
Crossref
D. E. Moody, F. Liu & W. B. Fang. (2013) In vitro Inhibition of Methadone and Oxycodone Cytochrome P450-Dependent Metabolism: Reversible Inhibition by H2-Receptor Agonists and Proton-Pump Inhibitors. Journal of Analytical Toxicology 37:8, pages 476-485.
Crossref
Crossref
Nadine E. Chen, Jaimie P. Meyer, Ann K. Avery, Jeffrey Draine, Timothy P. Flanigan, Thomas Lincoln, Anne C. Spaulding, Sandra A. Springer & Frederick L. Altice. (2011) Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees. AIDS and Behavior 17:8, pages 2654-2666.
Crossref
Crossref
Scott D. Campbell, Amanda Crafford, Brian L. Williamson & Evan D. Kharasch. (2013) Mechanism of Autoinduction of Methadone N-Demethylation in Human Hepatocytes. Anesthesia & Analgesia 117:1, pages 52-60.
Crossref
Crossref
Evan D. Kharasch & Kristi Stubbert. (2013) Role of Cytochrome P4502B6 in Methadone Metabolism and Clearance. The Journal of Clinical Pharmacology 53:3, pages 305-313.
Crossref
Crossref
Robert TaylorJr.Jr., Robert B. Raffa & Joseph V. PergolizziJr.Jr.. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy
183
200
.
E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London & T Kim. (2012) Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics. Clinical Pharmacology & Therapeutics 91:4, pages 673-684.
Crossref
Crossref